Altimmune Ownership | Who Owns Altimmune?

Overview Forecast RevenueFinancials Chart Transcripts

Altimmune Ownership Summary

Altimmune is owned by 55.50% institutional investors, 0.79% insiders, and 43.71% retail investors. Blackrock is the largest institutional shareholder, holding 7.52% of ALT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.52% of its assets in Altimmune shares.

ALT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Altimmune	55.50%	0.79%	43.71%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	5.32M	7.52%	$35.39M
Vanguard group	4.91M	6.93%	$32.63M
State street	3.91M	5.52%	$26.00M
Ameriprise financial	3.22M	4.55%	$21.44M
Tang capital management	2.75M	3.88%	$18.29M
Geode capital management	1.59M	2.25%	$10.60M
Morgan stanley	1.29M	1.82%	$8.59M
Knoll capital management	1.12M	1.58%	$7.46M
Goldman sachs group	1.01M	1.43%	$6.72M
Capital fund management	886.28K	1.25%	$5.89M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Knoll capital management	1.12M	5.03%	$7.46M
Tang capital management	2.75M	1.86%	$18.29M
Gerber	281.78K	1.47%	$1.87M
Beirne wealth consulting services	277.80K	0.74%	$1.85M
Pvg asset management	23.12K	0.61%	$153.75K
Portolan capital management	640.24K	0.35%	$4.26M
Gsa capital partners llp	488.13K	0.23%	$3.25M
Dcf advisers	42.87K	0.15%	$285.07K
Brown wealth management	50.00K	0.13%	$332.50K
Wealth effects	37.55K	0.09%	$249.71K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	4.91M	0.00%	1.78M
Ameriprise financial	3.22M	0.01%	1.51M
Blackrock	5.32M	0.00%	1.28M
Capital fund management	886.28K	0.02%	886.28K
Bellevue group	600.00K	0.06%	600.00K

Top Sellers

Holder	Shares	% Assets	Change
State street	3.91M	0.00%	-4.74M
Millennium management	13.36K	-	-1.58M
Fred alger management	-	-	-993.52K
Morgan stanley	1.29M	0.00%	-920.93K
Citigroup	36.38K	0.00%	-706.53K

New Positions

Holder	Shares	% Assets	Change	Value
Capital fund management	886.28K	0.02%	886.28K	$5.89M
Bellevue group	600.00K	0.06%	600.00K	$3.99M
Two sigma investments, lp	576.57K	0.01%	576.57K	$3.83M
Hennion & walsh asset management	129.28K	0.04%	129.28K	$859.68K
Exchange traded concepts	124.26K	0.02%	124.26K	$826.35K

Sold Out

Holder	Change
Financial gravity asset management	-4.00
Bok financial private wealth	-11.00
Nelson, van denburg & campbell wealth management group	-12.00
Principal securities	-18.00
Frazier financial advisors	-50.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	178	-4.81%	39,452,138	-6.90%	55	1.55%	81	-19.80%	43	-4.44%
Jun 30, 2024	186	2.20%	42,372,181	-4.53%	59	1.04%	100	-4.76%	45	9.76%
Mar 31, 2024	182	21.33%	44,383,417	33.54%	75	1.98%	105	9.38%	41	78.26%
Dec 31, 2023	150	25.00%	33,236,130	9.54%	61	1.73%	96	104.26%	23	-41.03%
Sep 30, 2023	120	-6.25%	30,341,585	-13.91%	59	1.21%	47	-29.85%	39	18.18%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.50M	3.52%	-84.26K
CT (Lux) American Smaller Com 9U USD	1.84M	2.59%	285.12K
CT American Smaller Coms(US) InstAccGBP	1.83M	2.58%	264.26K
iShares Russell 2000 ETF	1.83M	2.58%	-4.12K
SPDR® S&P Biotech ETF	1.72M	2.42%	19.01K
Vanguard Institutional Extnd Mkt Idx Tr	1.09M	1.54%	-3.41K
Fidelity Small Cap Index	727.87K	1.02%	-18.46K
Bellevue Healthcare Ord	600.00K	0.84%	600.00K
State St Russell Sm/Mid Cp® Indx NL Cl C	494.68K	0.70%	-14.60K
International Biotechnology Ord	473.87K	0.67%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 19, 2024	Drutz David	-	Sell	$54.24K
Aug 19, 2024	Drutz David	-	Sell	$56.31K
Aug 15, 2023	Drutz David	-	Buy	$862.50
Aug 12, 2022	GILL JOHN	-	Sell	$40.71K
Mar 23, 2023	Drutz David	-	Buy	$38.43K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	2
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

ALT Ownership FAQ

Who Owns Altimmune?

Altimmune shareholders are primarily institutional investors at 55.50%, followed by 0.79% insiders and 43.71% retail investors. The average institutional ownership in Altimmune's industry, Biotech Stocks , is 47.04%, which Altimmune exceeds.

Who owns the most shares of Altimmune?

Altimmune’s largest shareholders are Blackrock (5.32M shares, 7.52%), Vanguard group (4.91M shares, 6.93%), and State street (3.91M shares, 5.52%). Together, they hold 19.97% of Altimmune’s total shares outstanding.

Does Blackrock own Altimmune?

Yes, BlackRock owns 7.52% of Altimmune, totaling 5.32M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 35.39M$. In the last quarter, BlackRock increased its holdings by 1.28M shares, a 31.64% change.

Who is Altimmune’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Altimmune’s biggest shareholder by percentage of total assets invested, with 5.03% of its assets in 1.12M Altimmune shares, valued at 7.46M$.

Who is the top mutual fund holder of Altimmune shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Altimmune shares, with 3.52% of its total shares outstanding invested in 2.5M Altimmune shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools